what is being done about the thimerosal content of less commonly administered vaccines and other biological products given to infants, children, and pregnant women?
A. The FDA is continuing its efforts to reduce exposure to infants, children, and pregnant women to mercury from all sources. Discussions with the manufacturers of influenza vaccines (which are routinely recommended for pregnant women) regarding thimerosal-reduced and thimerosal-free presentations are ongoing. Discussions are also underway with regard to other vaccines, in particular, the diphtheria and tetanus vaccines and one manufacturer’s adolescent/adult formulation of the hepatitis B vaccine (a second manufacturer’s hepatitis B vaccine is formulated without thimerosal as a preservative for both the pediatric and adult presentations.) Q. What has the Federal government done to address the issue of mercury containing preservatives in vaccines? A. Under the FDA Modernization Act (FDAMA) of 1997, the FDA carried out a comprehensive review of the use of thimerosal in childhood vaccines. Conducted in 1999, this review found no evidence of harm from the use of thimerosal as a vaccine pr
Related Questions
- what is being done about the thimerosal content of less commonly administered vaccines and other biological products given to infants, children, and pregnant women?
- Is it necessary for infants or children to apply sunscreen? What kinds of products are applicable for them?
- How can it be given to infants and children too small to swallow a capsule?
- How can it be given to infants and children too small to swallow a capsule?
- What is known about the causes of autism?
- What is known about the causes of autism?
